Memorial Sloan Kettering on Monday opened its $185 million, 110,000-square-foot outpatient cancer care facility in Montvale. The new center is MSK’s third in New Jersey, with the two others located in Basking Ridge and Middletown.
U.S. Sen. Robert Menendez, D-N.J.; U.S. Rep. Josh Gottheimer, D-5th District; and state Commissioner of Health Dr. Shereef Elnahal were all on hand for the unveiling.
The new, two-story facility employs 35 oncologists and 190 clinicians and administrative staff, and features 28 exam rooms, 18 infusion bays and three treatment rooms for outpatient services. It also offers two linear accelerators for radiation therapy, and is one of the few facilities to offer immunotherapy, the newest form of cancer treatment.
While the facility is owned and operated by MSK, patients who need to be hospitalized can be sent to one of Hackensack Meridian Health’s 16 hospitals in the state through a partnership MSK and HMH formed 16 months ago.
“Our partnership with HMH will provide the highest quality cancer care in New Jersey, as well as holistic approaches. It will offer the latest advances in cancer care,” said Dr. Craig Thompson, MSK’s president.
“One out of every five patients of MSK call New Jersey home, and we have more patients from Bergen County than any other county in the state,” he said during the event. “That’s a major reason we built this facility. Our projections show that more and more cancer care will be administered in the outpatient setting, so this means that outpatient facilities will be crucial in cancer care.”
“The goal of our partnership is to develop and offer common clinical standards and a common standard of care for all cancer patients throughout our networks,” said Bob Garrett, HMH co-CEO, who also spoke at the event.
HMH and MSK plan to jointly open cancer centers in New Jersey over the next several years in areas of where cancer patients are underserved, Garrett said.